SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-014624
Filing Date
2019-03-18
Accepted
2019-03-18 16:16:02
Documents
62
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv515572_10k.htm 10-K 949054
2 EXHIBIT 23.1 tv515572_ex23-1.htm EX-23.1 2026
3 EXHIBIT 31.1 tv515572_ex31-1.htm EX-31.1 8337
4 EXHIBIT 31.2 tv515572_ex31-2.htm EX-31.2 8390
5 EXHIBIT 32.1 tv515572_ex32-1.htm EX-32.1 4084
6 EXHIBIT 32.2 tv515572_ex32-2.htm EX-32.2 4140
  Complete submission text file 0001144204-19-014624.txt   7477037

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mbio-20181231.xml EX-101.INS 2149293
8 XBRL TAXONOMY EXTENSION SCHEMA mbio-20181231.xsd EX-101.SCH 45945
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbio-20181231_cal.xml EX-101.CAL 40328
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbio-20181231_def.xml EX-101.DEF 326277
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20181231_lab.xml EX-101.LAB 352731
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20181231_pre.xml EX-101.PRE 368343
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38191 | Film No.: 19688407
SIC: 2834 Pharmaceutical Preparations